The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Official Title: A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)
Study ID: NCT03703297
Brief Summary: This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients with LS-SCLC Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Tucson, Arizona, United States
Research Site, Santa Rosa, California, United States
Research Site, New Haven, Connecticut, United States
Research Site, Fort Myers, Florida, United States
Research Site, Orange City, Florida, United States
Research Site, Saint Petersburg, Florida, United States
Research Site, Marietta, Georgia, United States
Research Site, Hines, Illinois, United States
Research Site, Fort Wayne, Indiana, United States
Research Site, Muncie, Indiana, United States
Research Site, Lexington, Kentucky, United States
Research Site, Annapolis, Maryland, United States
Research Site, Baltimore, Maryland, United States
Research Site, Towson, Maryland, United States
Research Site, Boston, Massachusetts, United States
Research Site, Detroit, Michigan, United States
Research Site, Grand Rapids, Michigan, United States
Research Site, Minneapolis, Minnesota, United States
Research Site, Summit, New Jersey, United States
Research Site, New Hyde Park, New York, United States
Research Site, Chapel Hill, North Carolina, United States
Research Site, Portland, Oregon, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Pittsburgh, Pennsylvania, United States
Research Site, Sioux Falls, South Dakota, United States
Research Site, Chattanooga, Tennessee, United States
Research Site, Nashville, Tennessee, United States
Research Site, Nashville, Tennessee, United States
Research Site, Dallas, Texas, United States
Research Site, Kennewick, Washington, United States
Research Site, Tacoma, Washington, United States
Research Site, Charleston, West Virginia, United States
Research Site, Huntington, West Virginia, United States
Research Site, Milwaukee, Wisconsin, United States
Research Site, Caba, , Argentina
Research Site, Caba, , Argentina
Research Site, Córdoba, , Argentina
Research Site, Mar del Plata, , Argentina
Research Site, Rosario, , Argentina
Research Site, Aalst, , Belgium
Research Site, Anderlecht, , Belgium
Research Site, Bruxelles, , Belgium
Research Site, Hasselt, , Belgium
Research Site, Roeselare, , Belgium
Research Site, Edmonton, Alberta, Canada
Research Site, Toronto, CA, Canada
Research Site, Winnipeg, Manitoba, Canada
Research Site, Hamilton, Ontario, Canada
Research Site, London, Ontario, Canada
Research Site, Ottawa, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Montreal, Quebec, Canada
Research Site, Beijing, , China
Research Site, Beijing, , China
Research Site, Beijing, , China
Research Site, Beijing, , China
Research Site, Beijing, , China
Research Site, Bengbu, , China
Research Site, Changchun, , China
Research Site, Changsha, , China
Research Site, Chengdu, , China
Research Site, Chongqing, , China
Research Site, Chongqing, , China
Research Site, Fuzhou, , China
Research Site, Hangzhou, , China
Research Site, Hefei, , China
Research Site, Shanghai, , China
Research Site, Shanghai, , China
Research Site, Shenyang, , China
Research Site, Shenyang, , China
Research Site, Tianjin, , China
Research Site, Wuhan, , China
Research Site, Wuhan, , China
Research Site, Wuhan, , China
Research Site, Yangzhou, , China
Research Site, Zhengzhou, , China
Research Site, Brno, , Czechia
Research Site, Olomouc, , Czechia
Research Site, Ostrava, , Czechia
Research Site, Praha 2, , Czechia
Research Site, Praha, , Czechia
Research Site, Berlin, , Germany
Research Site, Freiburg, , Germany
Research Site, Gauting, , Germany
Research Site, Gerlingen, , Germany
Research Site, Heidelberg, , Germany
Research Site, Köln, , Germany
Research Site, Mainz, , Germany
Research Site, Münster, , Germany
Research Site, Oldenburg, , Germany
Research Site, Regensburg, , Germany
Research Site, Wuerzburg, , Germany
Research Site, Bengaluru, , India
Research Site, Gurgaon, , India
Research Site, Brescia, , Italy
Research Site, Milano, , Italy
Research Site, Milano, , Italy
Research Site, Orbassano, , Italy
Research Site, Parma, , Italy
Research Site, Roma, , Italy
Research Site, Rozzano, , Italy
Research Site, Terni, , Italy
Research Site, Bunkyo-ku, , Japan
Research Site, Chuo-ku, , Japan
Research Site, Fukuoka-shi, , Japan
Research Site, Iwakuni-shi, , Japan
Research Site, Kashiwa, , Japan
Research Site, Koto-ku, , Japan
Research Site, Kurume-shi, , Japan
Research Site, Nagoya-shi, , Japan
Research Site, Nagoya-shi, , Japan
Research Site, Niigata-shi, , Japan
Research Site, Osakasayama, , Japan
Research Site, Sakai-shi, , Japan
Research Site, Sapporo-shi, , Japan
Research Site, Sendai-shi, , Japan
Research Site, Sunto-gun, , Japan
Research Site, Tokushima-shi, , Japan
Research Site, Ube-shi, , Japan
Research Site, Changwon-si, , Korea, Republic of
Research Site, Cheongju-si, , Korea, Republic of
Research Site, Daegu, , Korea, Republic of
Research Site, Goyang-si, , Korea, Republic of
Research Site, Jinju-si, , Korea, Republic of
Research Site, Seongnam-si, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Suwon-si, , Korea, Republic of
Research Site, Amsterdam, , Netherlands
Research Site, Den Bosch, , Netherlands
Research Site, Groningen, , Netherlands
Research Site, Harderwijk, , Netherlands
Research Site, Hengelo, , Netherlands
Research Site, Gdańsk, , Poland
Research Site, Olsztyn, , Poland
Research Site, Poznań, , Poland
Research Site, Tomaszów Mazowiecki, , Poland
Research Site, Warszawa, , Poland
Research Site, Wroclaw, , Poland
Research Site, Kazan, , Russian Federation
Research Site, Kirov, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Obninsk, , Russian Federation
Research Site, Omsk, , Russian Federation
Research Site, Ufa, , Russian Federation
Research Site, Volgograd, , Russian Federation
Research Site, Barcelona, , Spain
Research Site, Barcelona, , Spain
Research Site, Madrid, , Spain
Research Site, Madrid, , Spain
Research Site, Madrid, , Spain
Research Site, Oviedo, , Spain
Research Site, Sevilla, , Spain
Research Site, Valencia, , Spain
Research Site, Zaragoza, , Spain
Research Site, Hsinchu, , Taiwan
Research Site, Kaohsiung City, , Taiwan
Research Site, Keelung City, , Taiwan
Research Site, Taichung, , Taiwan
Research Site, Tainan City, , Taiwan
Research Site, Tainan, , Taiwan
Research Site, Taipei, , Taiwan
Research Site, Taipei, , Taiwan
Research Site, Taoyuan City, , Taiwan
Research Site, Yunlin, , Taiwan
Research Site, Adana, , Turkey
Research Site, Ankara, , Turkey
Research Site, Ankara, , Turkey
Research Site, Antalya, , Turkey
Research Site, Edirne, , Turkey
Research Site, Istanbul, , Turkey
Research Site, Izmir, , Turkey
Research Site, Konya, , Turkey
Research Site, Samsun, , Turkey
Research Site, Manchester, , United Kingdom
Research Site, Truro, , United Kingdom
Research Site, Hanoi, , Vietnam
Research Site, Ho Chi Minh, , Vietnam
Research Site, Ho Chi Minh, , Vietnam
Name: Haiyi Jiang, M.D.
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR